Immunocompromised clinical trials at UCLA

1 in progress, 0 open to eligible people

DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Sorry, not currently recruiting here
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Los Angeles, California and other locations

Last updated: November 18, 2024